Table 1.
Group | 1st Week | 2nd Week | ||
---|---|---|---|---|
P.V.R | P.R. | P.V.R. | P.R. | |
rMDV/ALV-env | 26.7% (4/15) | 73.3% (11/15) | 0.0% (0/15) | 100.0% (15/15) |
rMDV/ALV-gag+env | 33.3% (4/12) | 67.7% (8/12) | 0.0% (0/12) | 100% (12/12) |
No immune challenge | 55.5% (5/9) | 45.5% (4/9) | 25.0% (2/8) | 75% (6/8) |
No immune no challenge | 0.0% (0/5) | 100% (5/5) | 0.0% (0/5) | 100% (5/5) |
Note. P.V.R.: positive viremia ratios; P.R.: protection ratios.